Hikma Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HIKMA PHARMS, and what generic and branded alternatives to HIKMA PHARMS drugs are available?
HIKMA PHARMS has thirty-six approved drugs.
There are two tentative approvals on HIKMA PHARMS drugs.
Drugs and US Patents for Hikma Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma Pharms | BUPIVACAINE HYDROCHLORIDE | bupivacaine hydrochloride | INJECTABLE;INJECTION | 205141-001 | Feb 11, 2021 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hikma Pharms | ESCITALOPRAM OXALATE | escitalopram oxalate | TABLET;ORAL | 078766-001 | Sep 11, 2012 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Hikma Pharms | GLIMEPIRIDE | glimepiride | TABLET;ORAL | 078952-002 | Aug 1, 2013 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Hikma Pharms | SERTRALINE HYDROCHLORIDE | sertraline hydrochloride | TABLET;ORAL | 077864-003 | Aug 10, 2009 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.